Response to Maiucci et al. About the Study “Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study”
The Journals of Gerontology: Series A · 2023
DOI: 10.1093/gerona/glad039 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journals of Gerontology: Series A, 2023. Verfasst von Hélène Vallet und 2 weiteren Autor:innen. Beteiligte Einrichtung: Assistance Publique-Hôpitaux de Paris (APHP) , Department of Geriatric Medicine, Hôpital Saint Antoine, Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: COVID-19. Die Arbeit nennt 3 Literaturangaben.
Abstract (Originalsprache)
To the Editor, We thank Maiucci et al. for their interest in our study “Corticosteroid therapy in COVID-19 associated with in-hospital mortality in geriatric patients: a propensity matched cohort study” (1). We wish to provide some clarifications and responses. The authors hypothesize that our results are related to the different disease severity of patients with and without corticosteroids treatment. They also imply that not all our corticosteroid-treated patients received oxygen. This is not the case, but the rate of patients on oxygen is not reported in our manuscript, so we will provide some clarification. As a reminder, the first cohort (GERICOVID) included patients hospitalized between March and April 2020. The second cohort (GERICOCO) included patients hospitalized between November 2020 and March 2021. Between these two periods, the recommendations concerning corticosteroid therapy for COVID-19 had evolved significantly. Indeed, as described in the Methods, because of lack of recommendations before September 2020, several patients of the GERICOVID cohort received corticosteroids according to the local medical decision. For the GERICOCO cohort, according to the WHO recommendations (September 2020) (2), all patients with severe or critical COVID-19 (defined as oxygen saturation 30 breaths per minute) received corticosteroids. Thus, in GERICOVID, 73% of patients received oxygen, whereas in GERICOCO, 71% received oxygen. Moreover, in GERICOVID, of the 119 patients with corticosteroids, 97% received oxygen, and in GERICOCO, of the 416 patients with corticosteroids, 96% received oxygen. We chose to evaluate the disease severity of our patients according to two criteria: oxygen saturation
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Assistance Publique-Hôpitaux de Paris (APHP) , Department of Geriatric Medicine, Hôpital Saint Antoine, Sorbonne Université, Paris, France.
- Sorbonne Université, INSERM UMR1135, centre d'immunologie et des maladies infectieuses, Paris, France.
- Assistance Publique-Hôpitaux de Paris (APHP), Department of Geriatric Medicine, Hôpital Pitié Salpêtrière, Sorbonne Université, Paris, France.
- Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, Paris, France.
ORCID-Profile: Hélène Vallet
Zitieren
APA
Vallet, H., Boddaert, J., & Zerah, L. (2023). Response to Maiucci et al. About the Study “Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study”. The Journals of Gerontology: Series A. https://doi.org/10.1093/gerona/glad039
Vancouver
Vallet H, Boddaert J, Zerah L. Response to Maiucci et al. About the Study “Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study”. The Journals of Gerontology: Series A. 2023. doi:10.1093/gerona/glad039
BibTeX
@article{Vallet2023,
author = {Vallet, Hélène and Boddaert, Jacques and Zerah, Lorène},
title = {Response to Maiucci et al. About the Study “Corticosteroid Therapy in COVID-19 Associated With In-hospital Mortality in Geriatric Patients: A Propensity Matched Cohort Study”},
journal = {The Journals of Gerontology: Series A},
year = {2023},
doi = {10.1093/gerona/glad039}
}
EUVIMED